OTC supply problems impact GSK's sales

23 July 2014 - Deborah Wilkes

Archived

GlaxoSmithKline's Consumer Healthcare division reported worldwide sales down by 14% to £1.02 billion (US$1.74 billion) in the second quarter of 2014, as supply problems hit several brands including smoking-control products.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: